ARRC LED, LED LIGHT THERAPY FOR THE WHOLE BODY
GLOBAL LEADER: The ARRC LED is a world leader in the US based manufacturing of Full Body LED Light Therapy Beds. Our systems range from the mid dose, non-thermal EDGE POLY to our high dose ATP system. ARRC LED is and will continue to be an innovator and disrupter within this emerging industry. In 2019 alone we are introducing two new patent pending LED Light Therapy systems and initiating a number of clinical trials to evaluate how a whole body chamber affects the body.
The ARRC LED ATP system is extraordinarily powerful within the optimum dosing ranges for LED Light Therapy. That translates to shorter treatment times and deeper penetration into tissues and joints. ATP RF will likely create a revolution within the medical iudustry as it mixes modalities within the bed and optimizes treatments by directing condition specific pulsing protocols through the power of the lighting system.
The ARRC LED EDGE system is a mid power, affordable LED Light Therapy Bed that we consider spa first and performance second. A new affordable version of the EDGE will be introduced in late 2019 with increased power.
BROAD MARKET: Our LED Light Therapy Beds can be found in the homes of world leaders, corporate executives and in the training rooms of professional sports teams. Doctors are prescribing PBM for their patients, recovery centers are offering it for athletes and alternative health seekers. Spas are using PBM to help their clients look better from head to toe. The appeal of PBMt is broad and the ARRC LED presents multiple solutions.
INNOVATION: Researchers continue to conclude that some of the mechanisms behind LED Light Therapy or PBMt are still uncertain. Our belief is that there are multiple wavelengths of energy that create slightly different healing signatures inside the body. Green for example might differ in how it affects blood cells and therefor be more active for diabetic, neuropathy, acne and shingles patients. Red and infrared both have their own healing signatures. Even within each color, we believe that healing signatures vary. 420nm blue may be most effective for acne, while 450nm blue is better for SAD and 470nm blue is best for MRSA. They are all blue and each slight variation has different benefits.
Click for Photobiomodulation Research
Click for Photobiomodulation Videos
Call 855.502.2772 for Direct Consultation to learn more about how a full body LED Light Therapy Bed from the ARRC LED may be applied to your practice, the costs of operation, expectations and comparisons between ATP and other systems:
US MANUFACTURING & FDA REGISTERED LED LIGHT THERAPY
The EDGE, EDGE POLY and ATP and ATP RF LED Light Therapy Beds are designed, engineered and built in California.
Our systems are built in an ISO 9001, Military and FDA compliant manufacturing facility according to GMP, FDA Quality Management Systems and ISO protocols.
The ARRC LED is FDA Registered. The FDA allows for low level light therapy devices to be sold ‘over the counter’ (FDA Exempt), with the only claim of ‘minor aches and pains’.
The ARRC LED makes no claims as to the effectiveness of its systems for any condition other than minor aches and pains. Always consult with your doctor when treating a medical condition. The ARRC LED does not offer any medical advice, always consult with your physician when treating a condition..
THIS SAYS IT ALL
Read what researchers from Mass General, Harvard and Boston University conclude about LED Light Therapy.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790317/ 2.8. Downstream cellular response
There have been a large number of both animal model and clinical studies that demonstrated highly beneficial LLLT effects on a variety of diseases, injuries, and has been widely used in both chronic and acute conditions (see Figure 7). LLLT may enhance neovascularisation, promote angiogenesis and increase collagen synthesis to promote healing of acute (Hopkins et al. 2004) and chronic wounds (Yu et al. 1997). LLLT provided acceleration of cutaneous wound healing in rats with a biphasic dose response favoring lower doses (Corazza et al. 2007). LLLT can also stimulate healing of deeper structures such as nerves (Gigo-Benato et al.2004), tendons (Fillipin et al. 2005), cartilage (Morrone et al. 2000), bones (Weberet al. 2006) and even internal organs (Shao et al. 2005). LLLT can reduce pain (Bjordal et al. 2006a), inflammation (Bjordal et al. 2006b) and swelling (Carati et al. 2003) caused by injuries, degenerative diseases or autoimmune diseases. Oron reported beneficial effect of LLLT on repair processes after injury or ischemia in skeletal and heart muscles in multiple animal models in vivo (Ad and Oron 2001; Oron et al. 2001a; Oron et al. 2001b; Yaakobi et al. 2001). LLLT has been used to mitigate damage after strokes (in both animals (Lapchak et al. 2008) and humans (Lampl et al. 2007)), after traumatic brain injury (Oron et al. 2007) and after spinal cord injury (Wu et al. 2009).
Beneficial tissue effects of LLLT can include almost all the tissues and organs of the body.